| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 67,608 | 66,844 | 67,785 | 65,911 | | Cost of Revenue | 32,533 | 32,013 | 34,222 | 31,055 | | | Gross Profit | 35,075 | 34,831 | 33,563 | 34,856 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,783 | 1,369 | 1,582 | 3,282 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 23,425 | 21,720 | 23,556 | 25,057 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,867 | 11,742 | 8,425 | 6,517 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 672 | 1,128 | 695 | (2,229) | | Earnings Before Interest And Taxes | 10,112 | 13,097 | 9,320 | 15,748 | | Interest Expense | 13,835 | 14,050 | 14,051 | 14,472 | | Income Before Tax | (3,723) | (953) | (4,731) | 1,276 | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest | 7,508 | (3,764) | 3,764 | 4,234 | | | | Net Income From Continuing Ops | (3,248) | (4,717) | (967) | (5,858) | | | Non-recurring Events | | Discontinued Operations | (414) | 236 | 178 | (35) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,846 | (4,481) | (789) | (5,893) | | Preferred Stock And Other Adjustments | (6,601) | 4,201 | (1,200) |
-
| | | Net Income Applicable To Common Shares | ($2,755) | ($280) | ($1,989) | ($5,893) |
|
0.51% Nasdaq 
Income Statement
